- Home
- GHLD vs NAGE Comparison
GHLD vs NAGE Comparison
Compare GHLD & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHLD
- NAGE
- Stock Information
- Founded
- GHLD 1960
- NAGE 1999
- Country
- GHLD United States
- NAGE United States
- Employees
- GHLD N/A
- NAGE N/A
- Industry
- GHLD Finance: Consumer Services
- NAGE Medicinal Chemicals and Botanical Products
- Sector
- GHLD Finance
- NAGE Health Care
- Exchange
- GHLD Nasdaq
- NAGE Nasdaq
- Market Cap
- GHLD 977.9M
- NAGE 861.0M
- IPO Year
- GHLD 2020
- NAGE N/A
- Fundamental
- Price
- GHLD $19.85
- NAGE $11.08
- Analyst Decision
- GHLD Hold
- NAGE Strong Buy
- Analyst Count
- GHLD 6
- NAGE 3
- Target Price
- GHLD $17.90
- NAGE $16.67
- AVG Volume (30 Days)
- GHLD 145.3K
- NAGE 1.0M
- Earning Date
- GHLD 08-07-2025
- NAGE 08-06-2025
- Dividend Yield
- GHLD 2.52%
- NAGE N/A
- EPS Growth
- GHLD 63.18
- NAGE N/A
- EPS
- GHLD 0.71
- NAGE 0.18
- Revenue
- GHLD $1,131,796,000.00
- NAGE $107,925,000.00
- Revenue This Year
- GHLD $5.64
- NAGE $26.44
- Revenue Next Year
- GHLD $26.37
- NAGE $20.06
- P/E Ratio
- GHLD $27.85
- NAGE $61.85
- Revenue Growth
- GHLD 32.57
- NAGE 29.77
- 52 Week Low
- GHLD $11.21
- NAGE $2.53
- 52 Week High
- GHLD $20.15
- NAGE $14.69
- Technical
- Relative Strength Index (RSI)
- GHLD 81.32
- NAGE N/A
- Support Level
- GHLD $19.79
- NAGE N/A
- Resistance Level
- GHLD $20.02
- NAGE N/A
- Average True Range (ATR)
- GHLD 0.07
- NAGE 0.00
- MACD
- GHLD -0.18
- NAGE 0.00
- Stochastic Oscillator
- GHLD 43.33
- NAGE 0.00
About GHLD Guild Holdings Company
Guild Holdings Co is a growth-oriented mortgage company. It operates in two segments; The origination segment operates its loan origination business throughout the United States. It is responsible for loan origination, acquisition, and sale activities. This segment is further divided into retail and correspondent channel, and The servicing segment provides a steady stream of cash flow to support the origination segment more importantly it allows for the Company to build long-standing client relationships that drive repeat and referral business back to the origination segment to recapture the client's next mortgage transaction. It is responsible for the servicing activities of all loans in its servicing portfolio. It generates a majority of its revenue from the Origination segment.
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.